key: cord-0979244-k0wj4if1
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Comment on: ‘Pityriasis rubra pilaris‐like eruption following mRNA COVID‐19 vaccine’
date: 2022-03-26
journal: Clin Exp Dermatol
DOI: 10.1111/ced.15150
sha: 7987ac5c07e650dc3315a5e133081dfaf5d0a4d0
doc_id: 979244
cord_uid: k0wj4if1

Summary -

Dear Editor, We read with interest the recent article by Hunjan et al. 1 in Clinical and Experimental Dermatology on the appearance of a pityriasis rubra pilaris (PRP)-like eruption following administration of the BNT163b2 (Pfizer-BioN-Tech) mRNA COVID-19 vaccine. We agree that the COVID-19 vaccine may cause some adverse effects, such as skin irritation. A rash resembling PRP may appear, but it is not clear that this is linked to vaccination. It is usually difficult to draw any conclusions about such links because most reported cases have no information about the patient's immunological system or dermatological health prior to vaccination. It is also possible for a vaccine recipient to have an undiagnosed medical condition at the same time.

In the paper, the authors concluded that 'To our knowledge, this is the first reported case of PRP following administration of the BNT163b2 COVID-19 vaccine'. 1 

Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine

The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin